✦ LIBER ✦

PMS18 COST-EFFECTIVENESS OFABATACEPT IN PATIENTS WITH MODERATELYTO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN BRAZIL

✍ Scribed by MR Alves; F Carvalho Jr; G Litalien

Book ID: 118609514
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)70820-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS29 CANADIAN COST-EFFECTIVENESS ANALYS

PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

✍ D Zou; O Desjardins; N Tsao; R Goeree 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS35 Cost-Effectiveness of Tocilizumab

PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS33 Cost-Efficacy Analysis of Biologic

PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach

✍ A. Cafe; I. Monteiro; J.F. Loff; R. Encarnação 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Phase II study of tofacitinib (CP-690,55

Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

✍ Yoshiya Tanaka; Makoto Suzuki; Hiroyuki Nakamura; Shigeyuki Toyoizumi; Samuel H. 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 301 KB 👁 2 views